Search the Newsreel

5 Revealing Analyst Questions From Eli Lilly’s Q2 Earnings Call

5 Revealing Analyst Questions From Eli Lilly's Q2 Earnings Call Eli Lilly's second quarter was marked by a positive market reaction, despite the company missing Wall Street's revenue expectations. Management credited growth in key products—especially in cardiometabolic health, oncology, and neuroscience—as drivers of performance. …

2011 O'Reilly Auto Parts 200 Results

This article provides the complete race results for the 2011 O'Reilly Auto Parts 200 NASCAR Camping World Truck Series race, which was the 16th race of the season. Kevin Harvick won the race, leading 103 laps in his No. 2 Chevrolet. Johnny Sauter finished …

Scully Royalty names interim CEO and CFO as chairman steps in during leadership search

Scully Royalty Ltd. has appointed Chairman Michael Smith as interim CEO and CFO, replacing Samuel Morrow, who will remain a non-executive director. Smith will oversee executive functions while the company searches for permanent leadership. The company has committed to maintaining disciplined financial oversight during …

Bally's Corporation Q2 Results: Financials due August 14

Bally's Corporation is set to announce its Q2 2026 financial results on August 14, 2026, after market close. The company boasts a diverse portfolio including 20 casinos, the Bally Bet digital platform, and significant development rights in major U.S. cities. Notably, Bally's is the …

Eli Lilly cracks down on illicit weight loss drug trade with US lawsuits

Eli Lilly has launched a legal crackdown on US-based entities selling illicit versions of its investigational weight loss drug, retatrutide, filing six lawsuits against medical spas, compounding pharmacies, and online sellers. The company claims these entities are marketing products for "research use only" while …

O'Reilly Auto Parts to open in Richland Township

O'Reilly Auto Parts is scheduled to open on Saturday at the Bel-Air Plaza in Richland Township, Pennsylvania. This new store, along with other recent lease-ups, has significantly reduced vacancies at the plaza, which has also seen recent upgrades by its landlord, Jim Fox. The …

Ally Financial (ALLY) discloses $775M across 131 positions in new Form 13F

Ally Financial Inc. (ALLY) has filed its quarterly Form 13F, reporting equity securities holdings valued at $775,013,926 across 131 positions. The filing also includes holdings from two affiliated managers, Ally Insurance Holdings Inc. and Motors Insurance Corp. This report provides transparency into the institutional …

Renaissance Technologies discloses 5.66% Tilly's (TLYS) stake in Class A stock

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported a beneficial ownership of 5.66% in Tilly's, Inc. Class A common stock, amounting to 1,312,712 shares. Both entities hold sole voting and dispositive power over these shares, with certain managed funds having the right …

ORLY6480452 Bond Yield and Price — FINRA:ORLY6480452

This article provides detailed financial information on the O'Reilly Automotive, Inc. 5.05% bond maturing on August 14, 2031, with FINRA identifier ORLY6480452. It lists key terms such as outstanding amount, face value, coupon rate, and maturity date, along with issuer details and identifiers like …

O'Reilly Automotive issuing $1.6B in debt

O'Reilly Automotive plans to issue $1.6 billion in senior notes, with the closing expected on August 14. Further details of this development are accessible to subscribers only.

Chicago City Council Calls Bally’s Bluff, Demands Resort Construction Resume

The Chicago City Council is demanding that Bally's Corporation immediately resume full construction on its $1.7 billion casino resort after the company paused non-gaming related work. Bally's claims the city violated their Host Community Agreement by legalizing video gaming terminals (VGTs), which the casino …

Eli Lilly Shares Approach Record High While Retatrutide Legal Action Secures New Obesity Hope

Eli Lilly's shares are near a record high as the company files six lawsuits against alleged illegal sales of its experimental obesity drug, retatrutide. These legal actions aim to protect the drug's future market ahead of its planned U.S. submission in Q1 2027, given …

Sonida Senior Living enters $380 million term loan agreement with Ally Bank

Sonida Senior Living (NYSE:SNDA) has secured a new $380 million senior secured term loan agreement with Ally Bank, signed on August 7. This new financing amends and restates a previous agreement and adds to the company's substantial existing debt. The loan, maturing in five …

Scully Royalty Ltd. Provides Corporate Update

Scully Royalty Ltd. announced that its Chairman, Michael Smith, has been appointed interim Chief Executive Officer and Chief Financial Officer, replacing Samuel Morrow, who will now serve as a non-executive director. Mr. Smith will lead the company while it searches for permanent candidates for …

Zacks Research Has Optimistic Outlook of ORLY Q3 Earnings

Eli Lilly files 6 lawsuits against businesses selling 'black market' obesity drug

Eli Lilly has filed six lawsuits against businesses allegedly selling "black market" versions of its experimental obesity drug, retatrutide. The drug is currently in phase three clinical trials and is not yet approved by the FDA. The lawsuits target entities ranging from medical spas …

Ally Financial Inc. $ALLY Shares Purchased by Oldfield Partners LLP

Oldfield Partners LLP significantly increased its stake in Ally Financial Inc. by 27.4% in the second quarter, acquiring an additional 347,700 shares, bringing their total to 1.62 million shares valued at $74.2 million. This makes Ally Financial their second-largest holding, representing 17.9% of their …

Wise Ally Sets August Board Meeting to Approve Interim 2026 Results

Kelly Partners lifts FY26 revenue and scale as growth momentum eases

Kelly Partners Sets Earnings and Acquisition Targets to Lift Intrinsic Value

Eli Lilly tries to stop GLP-1 copycats

Eli Lilly has filed six lawsuits against US companies for allegedly selling unauthorized versions of its experimental obesity drug, retatrutide. The drugmaker emphasizes that retatrutide has not received FDA approval and carries significant risks. This action is part of Lilly's broader effort to combat …

Novo Nordisk CEO Concedes Eli Lilly’s Market-Share Gains as Stock Slumps

Novo Nordisk's CEO Mike Doustdar admitted that Eli Lilly is gaining market share in the GLP-1 drug market, leading to a slump in Novo's stock despite positive news like raised full-year sales guidance. Doustdar explained that price cuts for Ozempic and Wegovy to increase …

Trading the Move, Not the Narrative: (SBH) Edition

This article analyzes Sally Beauty Holdings Inc. (SBH), noting strong near and mid-term sentiment and significant upside potential due to a lack of resistance levels above the current price. It provides specific AI-generated trading strategies including long, breakout, and short positions with defined entry, …

With Chicago construction in limbo, what’s next for Bally’s Las Vegas?

Bally's Corp is facing uncertainty regarding its Las Vegas project following a pause in construction on its Chicago casino. While the A's MLB stadium is progressing on schedule for a 2028 debut on the former Tropicana site, questions arise about Bally's ability to finance …

Kelly Engineering® Named Leader and Star Performer on Everest Group's 2026 U.S. Contingent Talent and Strategic Solutions PEAK Matrix®

Kelly Engineering has been recognized as a Leader and Star Performer on Everest Group's 2026 U.S. Contingent Talent and Strategic Solutions PEAK Matrix® Assessment for the fifth and third consecutive years, respectively. The company also maintained its No. 4 position among U.S. engineering staffing …

Bet called: Chicago City Council insists Bally’s restart work on full River West casino development

The Chicago City Council is demanding that Bally's Corporation resume full construction on its River West casino development, including non-gaming amenities, despite Bally's pausing work in protest of the city legalizing video gambling. Aldermen sent a letter to Bally's, asserting that their contract requires …

O REILLY AUTOMOTIVE INC SEC Filing (Aug 12, 2026)

This article reports on an SEC Form 144 filing by O'Reilly Automotive Inc. (ORLY) on August 12, 2026. The filing indicates a proposed sale of 2000 shares of common stock with an aggregate market value of $183,707.32, acquired through restricted stock vesting. The shares …

O'Reilly Automotive Sells $1.6 Billion Senior Notes to Refinance Commercial Paper

O'Reilly Automotive has issued $1.6 billion in senior notes across three tranches to refinance a portion of its commercial paper. The net proceeds of approximately $1.59 billion will also be used for general corporate purposes, including working capital, share repurchases, and acquisitions. The agreement …

Eli Lilly Stock Falls While Retatrutide Lawsuits Expand

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY), the drug giant sitting at the center of the obesity boom, filed six lawsuits against businesses it says are illegally selling retatrutide. The timing is striking. Retatrutide is not approved. It is still in Phase …

Eli Lilly Sues Six Companies Over Unauthorized Retatrutide Sales

Eli Lilly has filed six lawsuits against U.S. companies for allegedly selling unauthorized versions of its experimental obesity drug, retatrutide. The lawsuits target compounding pharmacies, medical spas, and online sellers, as retatrutide is still in Phase 3 clinical trials and not yet approved by …

Lilly Targets Black-Market Retatrutide Sellers

This article first appeared on GuruFocus. Eli Lilly and Co. (LLY, Financials), the pharmaceutical company behind Zepbound and Foundayo, is stepping up its fight against unauthorized sellers of its experimental obesity drug retatrutide. Warning! GuruFocus has detected 8 Warning Sign with JPM. Is LLY …

Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market

Eli Lilly and Company is intensifying its efforts to combat the illegal black market for retatrutide, an unapproved investigational drug. The company has filed six new lawsuits against U.S. entities selling black-market products and is urging social media platforms, e-commerce sites, payment companies, and …

Eli Lilly sues six companies for selling illegal versions of groundbreaking weight-loss drug

Eli Lilly has filed lawsuits against six companies for illegally selling unapproved versions of its experimental weight-loss drug, retatrutide, which is still in Phase 3 trials. The pharmaceutical giant asserts that these black-market products are unverified and potentially life-threatening, and has called on social …

Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide

Eli Lilly has filed six new lawsuits to combat the black-market sale of its experimental obesity medicine, retatrutide. The drugmaker is taking action against online merchants, clinics, compounders, and foreign companies that claim to offer versions of its highly anticipated weight loss drug before …

Lilly takes 6 companies to court for selling retatrutide knockoffs

Eli Lilly has filed lawsuits against six companies in the United States for allegedly selling illegal, unapproved versions of its experimental weight-loss drug, retatrutide. These companies include compounding pharmacies, medical spas, and online sellers falsely claiming the knockoffs are for "research-use only." This action …

IBD 50 Stocks To Watch: Obesity Drug Giant Eli Lilly Offers New Buy Point

Obesity-drug giant Eli Lilly stock is approaching a new buy point as the ongoing stock market rally strengthens. Continue Reading